Christian Glennie
Stock Analyst at Stifel Nicolaus
(2.68)
# 2,949
Out of 4,651 analysts
103
Total ratings
36%
Success rate
2.9%
Average return
Main Sectors:
Stocks Rated by Christian Glennie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 315p | 230p | +37.20% | 11 | Aug 4, 2026 | |
| AIM: AMS Advanced Medical Solutions Group plc | Maintained: Buy | 245p | 281p | -12.81% | 12 | May 21, 2026 | |
| PLLWF Polarean Imaging plc | Maintained: Buy | $0.11 → $0.05 | $0.0066 | +719.79% | 9 | Sep 25, 2025 | |
| AIM: DXRX Diaceutics PLC | Maintained: Buy | 225p | 144p | +56.25% | 10 | Sep 23, 2025 | |
| AIM: EKF EKF Diagnostics Holdings plc | Maintained: Buy | 29p → 35p | 25p | +38.34% | 5 | Sep 16, 2025 | |
| LON: GNS Genus plc | Maintained: Hold | 1,850p → 2,300p | 2,256p | +1.95% | 7 | Sep 9, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,650p | 1,640p | n/a | 8 | Apr 24, 2025 | |
| INDV Indivior Pharmaceuticals | Maintained: Buy | $15 | $39.01 | n/a | 4 | Apr 24, 2025 | |
| AIM: UPR Uniphar plc | Reiterated: Buy | 393p → 406p | 365p | n/a | 5 | Mar 21, 2025 | |
| FRA: 4YL Nanoform Finland Oyj | Reiterated: Buy | €4.00 | €0.99 | n/a | 3 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9938 | n/a | 4 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 105p | 64p | n/a | 3 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €109.00 | €83.95 | n/a | 1 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €227.36 → €245.52 | €23.90 | n/a | 9 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 4,436p → 4,066p | 5p | n/a | 3 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 7,023p → 5,545p | 54p | n/a | 2 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 15,377p → 13,899p | 69p | n/a | 4 | Jun 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 12,938p | 0.13p | n/a | 3 | May 18, 2017 |
Convatec Group PLC
Aug 4, 2026
Reiterated: Buy
Price Target: 315p
Current: 230p
Upside: +37.20%
Advanced Medical Solutions Group plc
May 21, 2026
Maintained: Buy
Price Target: 245p
Current: 281p
Upside: -12.81%
Polarean Imaging plc
Sep 25, 2025
Maintained: Buy
Price Target: $0.11 → $0.05
Current: $0.0066
Upside: +719.79%
Diaceutics PLC
Sep 23, 2025
Maintained: Buy
Price Target: 225p
Current: 144p
Upside: +56.25%
EKF Diagnostics Holdings plc
Sep 16, 2025
Maintained: Buy
Price Target: 29p → 35p
Current: 25p
Upside: +38.34%
Genus plc
Sep 9, 2025
Maintained: Hold
Price Target: 1,850p → 2,300p
Current: 2,256p
Upside: +1.95%
Hikma Pharmaceuticals PLC
Apr 24, 2025
Reiterated: Buy
Price Target: 2,650p
Current: 1,640p
Upside: n/a
Indivior Pharmaceuticals
Apr 24, 2025
Maintained: Buy
Price Target: $15
Current: $39.01
Upside: n/a
Uniphar plc
Mar 21, 2025
Reiterated: Buy
Price Target: 393p → 406p
Current: 365p
Upside: n/a
Nanoform Finland Oyj
Nov 19, 2024
Reiterated: Buy
Price Target: €4.00
Current: €0.99
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $0.9938
Upside: n/a
May 23, 2024
Maintained: Buy
Price Target: 105p
Current: 64p
Upside: n/a
Nov 11, 2020
Downgraded: Hold
Price Target: €109.00
Current: €83.95
Upside: n/a
Nov 12, 2018
Reiterated: Buy
Price Target: €227.36 → €245.52
Current: €23.90
Upside: n/a
Jul 25, 2018
Reiterated: Buy
Price Target: 4,436p → 4,066p
Current: 5p
Upside: n/a
May 24, 2018
Maintained: Buy
Price Target: 7,023p → 5,545p
Current: 54p
Upside: n/a
Jun 8, 2017
Reiterated: Buy
Price Target: 15,377p → 13,899p
Current: 69p
Upside: n/a
May 18, 2017
Reiterated: Buy
Price Target: 12,938p
Current: 0.13p
Upside: n/a